Bellevue Group’s CareDx CDNA Stock Holding History

Bellevue Group’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14.7M	Sell	752,371 -136,632	-15%	-$2.67M	0.32%	56
2025 Q1	$15.8M	Sell	889,003 -485,409	-35%	-$8.62M	0.35%	57
2024 Q4	$29.4M	Sell	1,374,412 -1,771,044	-56%	-$37.9M	0.57%	44
2024 Q3	$98.2M	Sell	3,145,456 -767,119	-20%	-$24M	1.59%	19
2024 Q2	$60.8M	Sell	3,912,575 -21,431	-0.5%	-$333K	0.99%	26
2024 Q1	$41.7M	Sell	3,934,006 -20,786	-0.5%	-$220K	0.64%	50
2023 Q4	$47.5M	Buy	3,954,792 +13,994	+0.4%	+$168K	0.73%	44
2023 Q3	$27.6M	Buy	3,940,798 +224,321	+6%	+$1.57M	0.44%	65
2023 Q2	$31.6M	Buy	3,716,477 +277,386	+8%	+$2.36M	0.45%	64
2023 Q1	$31.4M	Buy	3,439,091 +270,643	+9%	+$2.47M	0.46%	61
2022 Q4	$36.2M	Buy	3,168,448 +567,002	+22%	+$6.47M	0.48%	62
2022 Q3	$44.3M	Buy	2,601,446 +63,922	+3%	+$1.09M	0.64%	47
2022 Q2	$54.5M	Buy	2,537,524 +226,348	+10%	+$4.86M	0.77%	44
2022 Q1	$85.5M	Buy	2,311,176 +844,624	+58%	+$31.2M	0.99%	34
2021 Q4	$66.7M	Buy	1,466,552 +1,435,609	+4,640%	+$65.3M	0.69%	50
2021 Q3	$1.96M	Sell	30,943 -117,928	-79%	-$7.47M	0.02%	148
2021 Q2	$13.6M	Sell	148,871 -41,500	-22%	-$3.8M	0.13%	119
2021 Q1	$13M	Sell	190,371 -153,612	-45%	-$10.5M	0.14%	114
2020 Q4	$24.9M	Sell	343,983 -771,920	-69%	-$55.9M	0.29%	89
2020 Q3	$42.3M	Sell	1,115,903 -50,936	-4%	-$1.93M	0.59%	50
2020 Q2	$41.3M	Sell	1,166,839 -110,212	-9%	-$3.9M	0.59%	46
2020 Q1	$27.9M	Buy	1,277,051 +100,321	+9%	+$2.19M	0.54%	49
2019 Q4	$25.4M	Buy	1,176,730 +454,075	+63%	+$9.79M	0.4%	55
2019 Q3	$16.3M	Buy	722,655 +230,647	+47%	+$5.21M	0.3%	67
2019 Q2	$17.7M	Buy	492,008 +60,440	+14%	+$2.18M	0.3%	60
2019 Q1	$13.6M	Sell	431,568 -104,920	-20%	-$3.31M	0.75%	45
2018 Q4	$13.5M	Buy	536,488 +199,439	+59%	+$5.01M	0.89%	34
2018 Q3	$9.72M	Buy	+337,049	New	+$9.72M	0.62%	52